R-BMD in Refractory or Relapsed Lymphoma, GELTAMO Clinical Trial

NCT01133158 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG: Rituximab, Bendamustine, Mitoxantrone, Dexamethasone

Sponsor

Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea